Federal Way's wellness culture drives strong interest in GLP-1 treatments. Ozempic® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk. Weight Method offers a separate program for Federal Way residents: licensed Washington providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month, with the provider evaluation, the medication, ongoing care, and home delivery to Federal Way included.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Federal Way is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Federal Way, WA. Weight Method offers compounded semaglutide, prescribed by licensed providers, from $199/month with virtual consultations and direct-to-door shipping.
Semaglutide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Novo Nordisk developed Ozempic® as the FDA-approved Injectable pen product, taken Once weekly, approved in 2017. Weight Method is a separate program: licensed providers in Washington evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for eligible Federal Way, WA residents starts at $199/month.
Suburban life around Federal Way comes with its own weight management challenges — car-dependent commutes, limited walkability, and the convenience of drive-throughs. Semaglutide therapy addresses biology involved in weight regulation by reducing hunger signals, so Federal Way area residents can break patterns that willpower alone cannot fix. Weight Method prescribes compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy, at $199/month, delivered to your door. Compounded Semaglutide is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Washington and start Ozempic from $199/month.
Get Started NowFree consultation. No commitment.